FUNGOFIN table. 250 mg. 14 table
FUNGOFIN table. 250 mg. 14 table
FUNGOFIN WHAT IS AND WHAT IT IS USED
FUNGOFIN belongs to a group of antifungal agents and is used to treat fungal infections of the skin, nails and scalp. Active e against strains of the following organisms: Trichophyton (T.rubrum and T.mentagrophytes, T. verrucosum, T. violaceum), Microsporum canis, Epidermophyton floccosum and Candida albicans. After taking terbinafine tablets reaches sufficient concentration to kill fungi or stop their growth.
FUNGOFIN tablets are indicated for the treatment of:
Onychomycosis (nail fungal infection) the toes or fingers caused by dermatophytes (tinea unguium)
Tinea capitis (fungal scalp)
Fungal infections of the skin, to treat tinea corporis (ringworm), tinea cruris (groin fungal infection) and tinea pedis (athlete foot)
Skin infections caused by yeasts of Candida (eg Candida albicans).
BEFORE YOU TAKE FUNGOFIN
Do not take FUNGOFIN
if you are allergic (hypersensitive) to terbinafine or any of the other ingredients of FUNGOFIN. An allergic reaction may be recognized by the presence of: rash, itching, redness of skin and difficulty breathing.
If you suffer from chronic or active liver disease.
Take special care with FUNGOFIN
Before treatment FUNGOFIN tell your doctor if you have impaired liver function or renal impairment.
Tell your doctor if during the intake FUNGOFIN you experience any of the following symptoms: nausea, anorexia (loss of appetite, psychological problem characterized by aversion to eating and fear of weight gain), fatigue, vomiting, pain right-sided abdominal or jaundice, dark urine or pale stools. If you have these symptoms, you should stop taking oral terbinafine and immediately assess liver function.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
It is an interaction with concomitant administration of terbinafine and the following drugs:
Cimetidine (used to treat ulcers) - can increase the level of blood terbinafine
Rifampicin (for tuberculosis) - can reduce the effects of terbinafine
Some antidepressants, beta-blockers (used to treat high blood pressure), caffeine - may increase levels of these drugs in the blood
Cyclosporine (used in transplant patients) - can reduce the level of this drug in the blood
Pregnancy and lactation
Ask your doctor or pharmacist before taking any medicine.
If you are pregnant or think you may be pregnant, contact your doctor.
FUNGOFIN should not be used during pregnancy unless clearly necessary. Your doctor will discuss with you the potential risks of taking FUNGOFIN during pregnancy.
During treatment FUNGOFIN should not breastfeed because terbinafine passes into breast milk and may harm your baby.
Driving and operating machinery
No data FUNGOFIN your ability to drive or operate machinery.
HOW TO TAKE FUNGOFIN
Always FUNGOFIN exactly as your doctor tells you. If you're not sure, ask your doctor or pharmacist.
The duration of treatment varies depending on the indication and the severity of infection.
The usual dose is 250 mg once daily (1 tablet FUNGOFIN day) orally.
Recommended duration of treatment:
Onychomycosis - 6 to 12 weeks (1 time daily)
Onychomycosis in hands - 6 weeks (1 time daily)
Onychomycosis legs - 12 weeks (1 time daily)
Tinea capitis - 4 to 6 weeks (1 time daily)
Tinea corporis, tinea cruris - 2 to 4 weeks (1 time daily)
Tinea pedis - 2-6 weeks (one a day)
Candidiasis / cutaneous candidiasis / - 2 to 4 weeks (1 time daily)
Onychomycosis: In most patients, treatment success was achieved in treatment duration between 6 and 12 weeks. Length less than three months may be considered in patients with infection involving the nails of the fingers, the nails of the toes without nail of the big toe or in younger patients. In the treatment of infections of the toenails three months is usually sufficient, but in a few patients may require therapy for six months or more.
Poor germination of the nail during the first weeks of treatment may indicate which patients require longer treatment. Your doctor will discuss this issue. Complete disappearance of the signs and symptoms of infection may not occur even several weeks after fungal therapy.
Application FUNGOFIN in children:
For children aged 3 to 16 years is taken into account in the diagram below, consistent with weight:
Children weighing 12 to 20 kg - 62,5 mg daily
Children weighing 20 to 40 kg - 125 mg daily
Children weighing> 40 kg - 250 mg daily
Application FUNGOFIN in the elderly:
No adjustment of dosage in elderly patients.
If you take more than the dose FUNGOFIN
If you take more than the dose FUNGOFIN immediately go to the nearest hospital and taking medicine or packaging with you or call your doctor.
Signs of overdose include headache, nausea, stomach pain, and dizziness. Recommended elimination of the product with activated charcoal and symptomatic therapy.
Do not exceed the recommended dose and duration of treatment.
If you forget to take FUNGOFIN
If you miss a tablet, take it as soon as you remember. Do not take it if the next administration is less than 4 hours. In this case, take the next dose at the regular time.
Do not take a double dose to make up for a forgotten tablet.
If you stop taking FUNGOFIN
Do not stop treatment before they have completed the full course of treatment. It is important to take the tablets each day and continue the treatment until your doctor terminate it. This will ensure complete cure of the infection and reduce the chance of re-emergence, and after you stop taking the tablets.
If you have any further questions on the use of this product, ask
Your doctor or pharmacist.
POSSIBLE SIDE EFFECTS
Like all medicines, FUNGOFIN can cause side effects, although not everybody gets them.
FUNGOFIN usually well tolerated. Side effects were mild to moderate and transient.
In this leaflet, when a side effect is described as "common", this means that they have been reported in more than 1 in every 100 patients but less than 1 in 10 patients.
When side effects were described as "uncommon", this means that they have been reported in more than 1 in 1,000 patients but less than 1 in 100 patients.
When side effects were described as "rare", this means that they have been reported in more than 1 in 10,000 patients, but less than 1 in 1000 patients.
When side effects were described as "very rare", this means that they have been reported in less than 1 in 10,000 patients, including some cases not known.
In some cases, any of the following side effects:
Blood and lymphatic system disorders:
Very rare: blood dyscrasia: a reduction in the number of white blood cells, which increases the likelihood of infection, reducing the number of platelets, which increases risk of bleeding or bruising
Immune system disorders:
Very rare: allergic reaction which causes difficulty in breathing or dizziness (including swelling of the face or throat), skin and systemic lupus erythematosus (disorder of the immune system that causes joint pain, skin rashes and fever)
Nervous system disorders:
Uncommon: taste disturbances, including taste loss, which is most often recovered several weeks after stopping the drug.
Very common: indigestion, feeling of fullness, loss of appetite, nausea, mild abdominal pain, diarrhea
Rare: biliary and liver problems
Skin and subcutaneous tissue disorders:
Very common: allergic skin reactions (skin rash with redness and itching)
Very rare: severe skin reactions (including Syndrome Stevens-Johnson), hair loss.
Musculo-skeletal and connective tissue disorders:
Very common: pain in muscles and joints
If any of the side effects gets serious, or you notice other effects not listed in
this leaflet, please tell your doctor or pharmacist.
HOW TO STORE FUNGOFIN
Keep out of reach of children.
Store in original container.
FUNGOFIN Do not use after the expiry date stated on the carton. The expiry date refers to the last day of that month.
The active substance is terbinafine. Each tablet contains terbinafinov hydrochloride equivalent to 250 mg of terbinafine.
The other ingredients are: hypromellose, croscarmellose sodium, microcrystalline cellulose, colloidal anhydrous silica, magnesium stearate.